AbbVie invests in Alector’s immunoneurology therapies for Alzheimer’s – Chemical & Engineering News

October 30, 2017 by  
Filed under Alzheimers News

Sponsored By

Chemical & Engineering News
AbbVie invests in Alector's immunoneurology therapies for Alzheimer's
Chemical & Engineering News
Alector's antibodies target microglia, while many in-development Alzheimer's therapies target amyloid-β or tau tangles. Credit: Alector. [+]Enlarge. Rosenthal.

and more »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!